3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Metastatic Urothelial Cancer
1
Glioblastoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
olaparib
4
Bevacizumab
3
niraparib
2
defactinib
2
Paclitaxel
2
Immunoglobulin G
2
Disulfides
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sodium thiosulfate
1
sapanisertib
1
rucaparib
1
relatlimab
1
relacorilant
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
durvalumab
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Ovarian Neoplasms
×
sacituzumab govitecan
×
Clear all
No trials found.